Hsa_circ_0044907 promotes acute myeloid leukemia progression through upregulating oncogene KIT via sequestering miR-186-5p
- PMID: 36004511
- DOI: 10.1080/16078454.2022.2113574
Hsa_circ_0044907 promotes acute myeloid leukemia progression through upregulating oncogene KIT via sequestering miR-186-5p
Abstract
Background: It has been reported that circular RNA hsa_circ_0044907 (circ_0044907) expression is overtly elevated in acute myeloid leukemia (AML) patient-derived BMMCs. However, the effect of circ_0044907 on AML progression remains un-clarified.
Methods: Expression of circ_0044907 in BM and AML cells were detected with real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR). Cell viability, proliferation, apoptosis, and cycle progression were determined by 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT), 5-ethynyl-2'-deoxyuridine (EDU), and flow cytometry assays. The regulatory mechanism of circ_0044907 was predicted by bioinformatics analysis and validated by dual-luciferase reporter, RNA pull-down, and RNA immunoprecipitation (RIP) assays. In vivo experiments were carried out to verify the function of circ_0044907.
Results: Circ_0044907 was overexpressed in AML patient-derived BM and AML cells. Furthermore, circ_0044907 could distinguish AML patients from healthy controls, and high circ_0044907 expression in BM had a poor prognosis for AML patients, implying that circ_0044907 served as a diagnostic and prognostic indicator for AML. Functionally, circ_0044907 silencing reduced cell viability, restrained cell proliferation, arrested cell cycle progression, and induced cell apoptosis in AML cells in vitro. Furthermore, circ_0044907 knockdown decreased AML cell growth in xenograft mouse models. Mechanically, circ_0044907 sponged miR-186-5p to block the inhibiting effect of miR-186-5p on KIT. Silenced miR-186-5p expression weakened circ_0044907 knockdown mediated suppression on AML cell viability, proliferation, and cycle progression. Also, forced KIT expression weakened miR-186-5p upregulation mediated inhibition on AML cell viability, proliferation, and cycle progression.
Conclusion: Circ_0044907 absorbed miR-186-5p to block the inhibiting impact of miR-186-5p on KIT, thus promoting AML progression.
Keywords: AML; KIT; circ_0044907; miR-186-5p.
Similar articles
-
CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia.Cancer Genomics Proteomics. 2024 Mar-Apr;21(2):118-136. doi: 10.21873/cgp.20434. Cancer Genomics Proteomics. 2024. PMID: 38423599 Free PMC article. Review.
-
Circ_0035381 contributes to the progression of acute myeloid leukemia via regulating miR-186-5p/CDCA3 pathway.Expert Rev Hematol. 2025 Apr-May;18(5):425-434. doi: 10.1080/17474086.2025.2484377. Epub 2025 Apr 22. Expert Rev Hematol. 2025. PMID: 40205799
-
Downregulation of circ_0012152 inhibits proliferation and induces apoptosis in acute myeloid leukemia cells through the miR-625-5p/SOX12 axis.Hematol Oncol. 2021 Oct;39(4):539-548. doi: 10.1002/hon.2895. Epub 2021 Jun 7. Hematol Oncol. 2021. PMID: 34097310
-
[Effects of circ-SFMBT2 on Proliferation, Migration and Invasion of Acute Myeloid Leukemia Cells by Regulating miR-491-5p/HOXA9 Axis].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Dec;31(6):1599-1607. doi: 10.19746/j.cnki.issn.1009-2137.2023.06.001. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 38071034 Chinese.
-
[Research Progress of Circular RNA in Acute Myeloid Leukemia --Review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Feb;32(1):282-286. doi: 10.19746/j.cnki.issn.1009-2137.2024.01.045. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024. PMID: 38387935 Review. Chinese.
Cited by
-
The emerging functions and clinical implications of circRNAs in acute myeloid leukaemia.Cancer Cell Int. 2025 Apr 29;25(1):167. doi: 10.1186/s12935-025-03772-4. Cancer Cell Int. 2025. PMID: 40296024 Free PMC article. Review.
-
Circular RNA as Diagnostic and Prognostic Biomarkers in Hematological Malignancies:Systematic Review.Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241285149. doi: 10.1177/15330338241285149. Technol Cancer Res Treat. 2024. PMID: 39512224 Free PMC article.
-
CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia.Cancer Genomics Proteomics. 2024 Mar-Apr;21(2):118-136. doi: 10.21873/cgp.20434. Cancer Genomics Proteomics. 2024. PMID: 38423599 Free PMC article. Review.
-
Diagnostic value of circular RNAs as promising hematological biomarkers in acute myeloid leukemia: A systematic review and meta-analysis.J Res Med Sci. 2025 May 26;30:31. doi: 10.4103/jrms.jrms_287_24. eCollection 2025. J Res Med Sci. 2025. PMID: 40503045 Free PMC article. Review.
-
Prognostic value of circular RNAs expression and their correlation with clinicopathological features in acute myeloid leukemia: a systematic review and meta-analysis.Ann Hematol. 2025 Apr;104(4):2095-2124. doi: 10.1007/s00277-025-06300-6. Epub 2025 Mar 15. Ann Hematol. 2025. PMID: 40087154 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous